A further development of the risk profile for severe postoperative hypocalcaemia after surgery for primary hyperparathyroidism (pHPT) was made with the aim of expanding the group of patients who can be discharged safely after 23 hours.
INTRODUCTION
Parathyroidectomy can be performed with a high success rate and low morbidity and no/low mortality (1-2). Several clinical series have reported the beneficial effect of surgery on muscle strength, self-reported physical and mental well-being, risk of fracture and increased bone density after surgery for pri-mary hyperparathyroidism (pHPT) (3-7). Furthermore, untreated pHPT increases the risk of cardiovascular mortality (8). The number of patients referred to surgical treatment of pHPT in our department has quadrupled over the last 12 years, and with this the associated cost. As a result, we need to evaluate the financial implications of parathyroid surgery. Recently, a questionnaire sent to all consultant members of the British Association of Endocrine Surgeons (BAES) in UK and Ireland (response rate 71.7 %) showed a normal hospital stay of 2.56 days, the vast majority of surgeons keep the patients in hospital for 2-3 days (9). In our department, risk of postoperative hypocalcaemia is the commonest reason for keeping patients in hospital for more than 23 hours after surgery.
Multivariate analysis of clinical and biochemical data including the weight of the gland removed, serum osteocalcin concentration, history of cardiovascular disease and the type and extent of surgery performed have all been shown to be associated with the risk of postoperative hypocalcaemia (10) (11) .
We had previously shown that 52 of 88 (59 %) patients with PTH <25 pmol/L, no previous neck surgery, biopsy/excision of <3parathyroid glands and no concomitant thyroid surgery could safely be discharged the day following surgery (12) . In these parathyroid operations (348 + 88 operations in a retrospective and a prospective setting, respectively), 35 patients had PTH >25 pmol/L as the only risk factor. None of the patients with a PTH value between 25-35 pmol/L from this subgroup developed severe postoperative hypocalcaemia. In the present study, a further development of the risk profile was made with the aim of expanding the group of patients who can be discharged safely after 23 hours. The risk factors evaluated were preoperative serum concentration of PTH of more than 35 pmol/L (five times the upper reference value), a history of previous neck surgery, incisional biopsy/excision of more than 2 parathyroid glands or concomitant thyroid surgery.
PATIENTS AND METHODS
Between January 2001 and December 2002, 156 patients (31 men and 125 women) underwent 158 parathyroid operations for pHPT. Their median age was 62 years (range 27-90 yr). Twenty-four patients had a history of renal stones, 5 patients had MEN1 and 2 patients had thyrotoxicosis. Median preoperative serum concentration of ionised calcium was 1.53 mmol/L (range 1.28-2.11, reference range 1.15 to 1.35).
Of the 146 (93 %) of patients that had not undergone previous neck surgery, bilateral exploration was performed in 135 (92 %) patients with the aim of identifying all four glands and unilateral exploration were performed in the remaining 11 (8 %) patients. Identification of parathyroid tissue was confirmed by frozen section. Definite diagnosis was established by conventional histological criteria (13) .
Risk factors validated for severe hypocalcaemia were preoperative serum concentration of parathyroid hormone (PTH) of more than 35 pmol/L (five times the upper reference value, reference range 1.1 to 6.9), a history of previous neck surgery, incisional biopsy/excision of more than 2 parathyroid glands or concomitant thyroid surgery.
For analysis, patients were stratified into one of four groups based on the preoperative and peroperative identified risk factors for severe postoperative hypocalcaemia.
Severe postoperative hypocalcaemia was defined as serum ionised calcium <1.00 mmol/L (reference range 1.15-1.35) (14) . Symptoms of hypocalcaemia were noted, as the requirement for vitamin D and/or calcium supplementation.
Patients were in hospital surveillance until the serum ionised calcium concentration was rising.
Indication for vitamin D substitution was falling calcium levels in symptomatic patients with oral or intravenous calcium substitution.
Statistical analyses performed by using Wilcoxon ranksum test.
RESULTS
A solitary parathyroid adenoma was identified in 129 operations (82 %), hyperplasia in 16 (10 %) and adenoma/hyperplasia was found in 1 operation (< 1%). Two adenomas were found in 2 (1 %), one of which also had an enlarged parathyroid gland with hyperplasia. A solitary adenoma together with an enlarged parathyroid gland with hyperplasia were found in 3 (2 %) and parathyroid cancer in 2 operations (1 %). No histological confirmation of the biochemical diagnosis was established in 5 operations (3 %). The median hospital stay was 3 days (range 1-8 days). Postoperatively, calcium levels were normalized in 94 % (148/158) of the patients. Seven (70 %) out of 10 patients with elevated postoperative calcium levels had an exploration of four parathyroid glands.
The grouping of patients according to their risk factors is laid out in table 1. In 131 procedures no preoperative risk factor for severe postoperative hypocalcaemia were identified. However, 21 patients of this group were considered to be at risk due to peroperative risk factors (Table 1 ). The remaining 110 operations (70 % of all operations performed) remained in the group without any risk factors post surgery (Table 1) , and none of them developed severe hypocalcaemia or received vitamin D substitution ( Table 2) . One of the patients received, due to symptoms, a single dose calcium infusion (nadir serum ionised calcium 1.10 mmol/L). Of the 21 procedures defined as risk of severe postoperative hypocalcaemia on the basis of surgery on more than 2 parathyroid glands or concomitant thyroid surgery, only 1 developed severe hypocalcaemia (Table 1) .
If we examine the 48 procedures (30 %) with risk factor(s) for severe postoperative hypocalcaemia as a whole they had significantly lower postoperative serum ionised calcium concentrations as compared to the group without any risk factor (p < 0.01) ( Table  2 ). The nine patients (19 %) who developed severe postoperative hypocalcaemia requiring treatment all belonged to the risk group. This gives the criteria a sensitivity of 100 % (9/9), and specificity of 74 % (110/149) in predicting significant postoperative hypocalcaemia.
The most common single factor predicting severe postoperative hypocalcaemia was a PTH of >35 pmol/L (five times the upper reference value, refer-ence range 1.1 to 6.9) which was present in 7 of 9 patients (in 3 combined with other risk factors). Concomitant thyroid surgery was present in 4/9, in 3 of these combined with other risk factors.
Seventeen of the 48 patients with at least one risk factor had a preoperative serum parathyroid hormone concentration which was more than 35 pmol/ L ( Table 1) . Seven of these (41 %) developed severe hypocalcaemia and 6 patients (35 %) received vitamin D substitution (Table 2) . Of the remaining 31 patients with PTH less than 35 pmol/L in the presence of any other risk factor(s), 2 patients (6 %) developed severe hypocalcaemia and 5 (16 %) received vitamin D substitution.
None of the patients who underwent a unilateral procedure were predicted as being likely to develop severe postoperative hypocalcaemia.
DISCUSSION
In a previous study we defined risk factors for severe post parathyroidectomy hypocalcaemia (12) . These predicted severe postoperative hypocalcaemia with a sensitivity of 100 % and specificity of 66 %. With an increase in the cut off serum PTH concentration from 25 to 35 pmol/L specificity has been maintained 100 % with an increased sensitivity of 74 %. Of great importance is a negative predictive value of 100 % meaning that if a patient does not have any of the predictive factors present there is no risk of becoming severely hypocalcaemic.
A majority of the patients (110/158, 70 %) had no risk factor and none of them developed severe postoperative hypocalcaemia or received vitamin D substitution. Eleven (10 %) had symptoms of hypocalcaemia and 12 (11 %) were discharged from hospital with calcium substitution. Sending them home earlier after surgery with calcium supplementation if needed on a symptomatic basis could decrease postoperative median hospital stay to one day as opposed to the more common 2-3 days.
Patients with risk factors for severe postoperative hypocalcaemia could be divided into 2 groups. A "higher risk group" defined by a preoperative PTH levels > 35 pmol/L (n =17) (five times the upper reference value) and a "lower risk group" with PTH <35 pmol/L (n =31). The majority of the patients suffering severe postoperative hypocalcaemia (7/9) belonged to the former group. The relatively high risk for severe postoperative hypocalcaemia among these patients (7/17 (41 %)) suggest that they should undergo in-hospital surveillance until the serum calcium level has stabilised on an acceptable level with or without calcium and/or vitamin D supplementation. The significance of increased levels of PTH have previously been shown in patients with postoperative hungry bone syndrome, whilst serum concentration of calcium measured preoperatively seems to underestimate the presence of advanced disease in patients in whom the bones are affected (10, 15) . When providing short hospital stay it is of importance to be aware of the 41 % risk of severe hypocalcaemia in the higher risk group (9.2 % of the patients), otherwise the complications with severe postoperative hypocalcaemia might pass without sufficient notice if the number of operations due to pHPT is small. Of the patients with a PTH concentration less than 35 pmol/L in the presence of other risk factors, only 2 out of 31 (6 %) developed severe hypocalcaemia. This might indicate that an early discharge from hospital is possible when combined with serum calcium measurement on a daily basis/every second day, until the nadir calcium level is reached. This may need to be combined with calcium and vitamin D supplementation. This strategy might further increase the number of patients that could have an early discharge from hospital.
Eleven patients without a history of prior thyroid/ parathyroid surgery had a unilateral parathyroid exploration. It might be expected that this group had a low/zero risk of developing severe hypocalcaemia. Unilateral neck exploration is associated with a lower incidence of biochemical and early severe symptomatic hypocalcaemia (16) . However, it is not clear if the higher incidence of postoperative hypocalcaemia in patients undergoing bilateral neck dissection is due to disruption of the blood supply to the glands caused by the neck dissection or biopsies from normal parathyroid glands (16) . This might indicate that this surgical approach may decrease the risk of severe postoperative hypocalcaemia in patients with PTH >35pmol/L. Further studies on this subject are needed. Few of our patients, without risk factors for severe postoperative hypocalcaemia, were discharged with calcium substitution (11 %, 12/110) and none of them received vitamin D substitution. This might indicate the benefit with unilateral exploration is limited when it comes to hypocalcaemia in this large subgroup of patients. Any removal of the patients with unilateral parathyroid exploration in our material had no impact on the statistical differences in postoperative plasma calcium levels between patients without any risk factor, and the three different groups of patients with risk factors. Furthermore, there was no difference between the patients with unilateral exploration v.s. the remaining patients without any risk factor concerning postoperative symptoms of hypocalcaemia and the number of patients with calcium substitution at discharge from hospital. However, it can not be excluded that preoperative localization procedures, combined with intraoperative PTH measurements could increase the success rate after surgery without increasing risk for postoperative hypocalcaemia in patients without risk-factors for severe postoperative hypocalcaemia (16) .
Patients with no risk factor can have a safe discharge from hospital on the first postoperative day with a supply of calcium tablets to take if required on symptomatic basis. Patients with preoperative serum concentration of PTH of more than 35 pmol/L (five times the upper reference value) should stay in hospital until the nadir level of plasma calcium is reached. Patients with serum concentration of PTH of less than 35 pmol/L in the presence of other risk factors may have an early discharge from hospital (second postoperative day) combined with outpatient measurements of plasma calcium levels and in some cases vitamin D substitution. A majority of the patients (127/158) (80 %) can have a proper preoperative planning for their hospital stay, and for the remaining patients (31/158) (20 %) early discharge from hospital combined with outpatient controls of plasma calcium levels or in-hospital surveillance could be chosen according to patient preference and availability of outpatient calcium measurements.
